Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IMV - IMV names Jeremy Graff as chief scientific officer

IMV - IMV names Jeremy Graff as chief scientific officer

IMV Inc.
Clinical-stage biopharmaceutical company IMV (IMV) announces the appointment of Jeremy Graff as the company's chief scientific officer, effective as of June 14, 2021. Graff brings over 20 years of experience in preclinical and clinical research and translational analysis for novel immune-activating therapeutics in oncology.Most recently, he served as Chief Development Officer and Senior Vice President, Research at HiberCell, a biotechnology company developing novel therapeutics for cancer relapse and metastasis. IMV also appointed former Bristol-Myers Squibb executive Stanley Frankel as a clinical advisor to support development of maveropepimut-S (formerly known as DPX-Survivac) in diffuse large B-cell lymphoma ((DLBCL)) and the initiation of next clinical trial in advanced ovarian cancer.

For further details see:

IMV names Jeremy Graff as chief scientific officer
Stock Information
Company Name: IMV Inc.
Stock Symbol: IMV
Market: NASDAQ
Website: imvinfo.com
Menu
IMV IMV Quote IMV Short IMV News IMV Articles IMV Message Board
Get IMV Alerts

News, Short Squeeze, Breakout and More Instantly...